IGHE and B-cell chronic lymphocytic leukemia: Prospective studies have observed lower plasma levels of IgE to be associated with increased risk of CLL [5, 6], implicating impaired immune function in CLL risk; however, the biologic mechanisms by which these immune-related conditions alter risk are unclear.